Macrocin
Appearance
Names | |
---|---|
IUPAC name
2-[(4R,5S,7R,9R,11E,13E,16R)-6-[[(2R,3R,4R,5S,6R)-5-[[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-2-tetrahydropyranyl]oxy]-4-dimethylamino-3-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-15-[[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-methoxy-6-methyl-2-tetrahydropyranyl]oxymethyl]-16-ethyl-4-hydroxy-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde
| |
Other names
Tylosin C
| |
Identifiers | |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
PubChem CID
|
|
| |
| |
Properties | |
C45H75NO17 | |
Molar mass | 902.07 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Macrocin is a macrolide antibiotic. Biosynthetically, it is produced from demethylmacrocin by demethylmacrocin O-methyltransferase[1] and is converted to tylosin, an antibiotic used in veterinary medicine, by macrocin O-methyltransferase.[2]
References
- ^ EC 2.1.1.102 at IUBMB
- ^ EC 2.1.1.101 at IUBMB